Epidemic Keratoconjunctivitis Medication
- Author: Ahmed Bawazeer, MB, ChB, FRCS(C); Chief Editor: Hampton Roy Sr, MD more...
Medication Summary
The goals of pharmacotherapy are to reduce morbidity and to prevent complications. The topical steroids dexamethasone, fluorometholone, prednisolone ophthalmic, and rimexolone 1% are used in the treatment of epidemic keratoconjunctivitis.
Corticosteroids
Class Summary
Topical corticosteroids are a group of anti-inflammatory agents that cause inhibition of the inflammatory response by potentiation of epinephrine vasoconstriction, stabilization of lysosomal membranes, decrease in macrophage movement, prevention of kinin release, interference with lymphocytes and neutrophil function, and inhibition of prostaglandin synthesis through inhibition of phospholipase enzyme.
Dexamethasone (Maxidex, Ozurdex)
Dexamethasone is used for various allergic and inflammatory diseases. It decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reducing capillary permeability.
Fluorometholone (FML, Flarex, FML Forte)
This agent suppresses the migration of polymorphonuclear leukocytes and reverses capillary permeability.
Prednisolone ophthalmic (Pred Forte, Omnipred, Pred Mild)
Prednisolone ophthalmic decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing increased capillary permeability.
Rimexolone 1% (Vexol)
Rimexolone decreases inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing increased capillary permeability.
Ocular Lubricants
Class Summary
These agents are used for symptomatic relief.
Artificial tears (Refresh Tears, Akwa Tears, Bion Tears, Murine Tears)
Artificial tears act to stabilize and thicken the precorneal tear film and prolong tear film breakup time, which occurs with dry eye states.
Romanowski EG, Yates KA, Gordon YJ. Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model. Antiviral Res. Dec 2001;52(3):275-80. [Medline].
Hillenkamp J, Reinhard T, Ross RS, Bohringer D, Cartsburg O, Roggendorf M, et al. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology. May 2002;109(5):845-50. [Medline].
Yamazaki ES, Ferraz CA, Hazarbassanov RM, Allemann N, Campos M. Phototherapeutic keratectomy for the treatment of corneal opacities after epidemic keratoconjunctivitis. Am J Ophthalmol. Jan 2011;151(1):35-43.e1. [Medline].
Sambursky R, Tauber S, Schirra F, Kozich K, Davidson R, Cohen EJ. The RPS adeno detector for diagnosing adenoviral conjunctivitis. Ophthalmology. Oct 2006;113(10):1758-64. [Medline].

